Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco

被引:44
作者
Henley, S. Jane
Connell, Cari J.
Richter, Patricia
Husten, Corinne
Pechacek, Terry
Calle, Eugenia E.
Thun, Michael J.
机构
[1] Amer Canc Soc, Epidemiol & Surveillancce Res, Atlanta, GA 30329 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Off Smoking & Hlth, Atlanta, GA 30333 USA
关键词
D O I
10.1136/tc.2006.018069
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Although several epidemiological studies have examined the mortality among users of spit tobacco, none have compared mortality of former cigarette smokers who substitute spit tobacco for cigarette smoking ("switchers'') and smokers who quit using tobacco entirely. Methods: A cohort of 116 395 men were identified as switchers ( n = 4443) or cigarette smokers who quit using tobacco entirely ( n = 111 952) when enrolled in the ongoing US American Cancer Society Cancer Prevention Study II. From 1982 to 31 December 2002, 44 374 of these men died. The mortality hazard ratios ( HR) of tobacco- related diseases, including lung cancer, coronary heart disease, stroke and chronic obstructive pulmonary disease, were estimated using Cox proportional hazards regression modelling adjusted for age and other demographic variables, as well as variables associated with smoking history, including number of years smoked, number of cigarettes smoked and age at quitting. Results: After 20 years of follow- up, switchers had a higher rate of death from any cause ( HR 1.08, 95% confidence interval ( CI) 1.01 to 1.15), lung cancer ( HR 1.46, 95% CI 1.24 to 1.73), coronary heart disease ( HR 1.13, 95% CI 1.00 to 1.29) and stroke ( HR 1.24, 95% CI 1.01 to 1.53) than those who quit using tobacco entirely. Conclusion: The risks of dying from major tobacco- related diseases were higher among former cigarette smokers who switched to spit tobacco after they stopped smoking than among those who quit using tobacco entirely.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 34 条
[1]   Cancer incidence among a cohort of smokeless tobacco users (United States) [J].
Accortt, NA ;
Waterbor, JW ;
Beall, C ;
Howard, G .
CANCER CAUSES & CONTROL, 2005, 16 (09) :1107-1115
[2]   Chronic disease mortality in a cohort of smokeless tobacco users [J].
Accortt, NA ;
Waterbor, JW ;
Beall, C ;
Howard, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (08) :730-737
[3]  
[Anonymous], REP CARC
[4]  
[Anonymous], 2004, HLTH CONS SMOK REP S
[5]   Smokeless tobacco as a possible risk factor for stroke in men - A nested case-control study [J].
Asplund, K ;
Nasic, S ;
Janlert, U ;
Stegmayr, B .
STROKE, 2003, 34 (07) :1754-1759
[6]   SMOKELESS TOBACCO USE AND INCREASED CARDIOVASCULAR MORTALITY AMONG SWEDISH CONSTRUCTION WORKERS [J].
BOLINDER, G ;
ALFREDSSON, L ;
ENGLUND, A ;
DEFAIRE, U .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (03) :399-404
[7]  
Breslow NE, 1987, STAT METHODS CANC RE, VII
[8]   Chemical profile of two types of oral snuff tobacco [J].
Brunnemann, KD ;
Qi, J ;
Hoffmann, D .
FOOD AND CHEMICAL TOXICOLOGY, 2002, 40 (11) :1699-1703
[9]   UTILITY OF THE NATIONAL DEATH INDEX FOR ASCERTAINMENT OF MORTALITY AMONG CANCER PREVENTION STUDY-II PARTICIPANTS [J].
CALLE, EE ;
TERRELL, DD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (02) :235-241
[10]   The American Cancer Society Cancer Prevention Study II nutrition Cohort - Rationale, study design, and baseline characteristics [J].
Calle, EE ;
Rodriguez, C ;
Jacobs, EJ ;
Almon, ML ;
Chao, A ;
McCullough, ML ;
Feigelson, HS ;
Thun, MJ .
CANCER, 2002, 94 (02) :500-511